Skip to search formSkip to main contentSkip to account menu

Claudiximab

A chimeric monoclonal antibody directed against the antigen GC182 with potential immunostimulatory and antineoplastic activities. Upon administration… 
National Institutes of Health

Search for papers about Claudiximab

Search papers